Sanofi Divests Enjaymo Rights to Recordati in a $825 Million Deal
Oct 5, 2024
Sanofi Stock Market Invest
Positive Results for Dupixent in Phase 3 Study for CSU Patients
Sep 12, 2024
Sanofi Considers Spinning Off Consumer Health Division in Potential $20B Deal
Nov 17, 2023